Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 8/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.37 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.37 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8954007 | 0.93 | DNM1 (0.40) | DNM1MEN1KMT2AALDH1A1TSHR | |
| SCHEMBL569445 | 0.89 | DNM1 (0.40) | DNM1MEN1KMT2AALDH1A1TSHR | |
| SCHEMBL704381 | 0.89 | ADRB2 (0.39) | ALDH1A1TSHRADRB2ADRB1ADRB3 | |
| SCHEMBL379680 | 0.87 | DNM1 (0.44) | DNM1MEN1KMT2AALDH1A1TSHR | |
| SCHEMBL2872173 | 0.85 | CA12 (0.45) | MEN1KMT2AALDH1A1TSHRCA1 | |
| SCHEMBL30775008 | 0.85 | DNM1 (0.48) | DNM1MEN1KMT2AALDH1A1TSHR | |
| SCHEMBL11332079 | 0.84 | TSHR (0.40) | MEN1KMT2ATSHRADRB2ADRB1 | |
| SCHEMBL5572088 | 0.84 | TSHR (0.40) | MEN1KMT2ATSHRADRB2ADRB1 | |
| SCHEMBL5575092 | 0.84 | TSHR (0.40) | MEN1KMT2ATSHRADRB2ADRB1 | |
| SCHEMBL706738 | 0.84 | ADRB2 (0.39) | ALDH1A1TSHRADRB2ADRB1ADRB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2771379-A2 | POLYMER, COMPOSITIONS AND PROCESS FOR PREPARING THEM | DSM IP Assets B.V. (NL) | 2014-09-03 | — | — | EP | claimed |
| US-20140242399-A1 | POLYMER, COMPOSITIONS AND PROCESS FOR PREPARING THEM | DSM IP ASSETS B.V. (NL) | 2014-08-28 | — | — | US | claimed |
| WO-2013060767-A2 | POLYMER, COMPOSITIONS AND PROCESS FOR PREPARING THEM | DSM IP ASSETS B.V. (NL) | 2013-05-02 | — | — | WO | claimed |
| US-12594700-B2 | Coatings from polyisocyanurate coatings (rim) and their use in injection molding processes | COVESTRO DEUTSCHLAND AG (DE) | 2026-04-07 | — | — | US | disclosed |
| US-12331214-B2 | Resistant 2K-PUR coatings | COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) | 2025-06-17 | — | — | US | disclosed |
| EP-3994192-B1 | RESISTANT 2K-PUR COATINGS | COVESTRO DEUTSCHLAND AG (DE) | 2025-04-30 | — | — | EP | disclosed |
| US-20250043146-A1 | MULTILAYER CONSTRUCTION ON METAL SUBSTRATES BASED ON POLYASPARTATE COATINGS | COVESTRO DEUTSCHLAND AG (DE) | 2025-02-06 | — | — | US | disclosed |
| EP-4453107-A1 | MULTILAYER CONSTRUCTION ON METAL SUBSTRATES BASED ON POLYASPARATE COATINGS | Covestro Deutschland AG (DE) | 2024-10-30 | — | — | EP | disclosed |
| US-20240294798-A1 | Coating Agents and Coatings That Are Obtainable Therefrom and Have Improved Resistance to Soiling and (Self-) Cleaning Properties | COVESTRO DEUTSCHLAND AG (DE) | 2024-09-05 | — | — | US | disclosed |
| EP-3271411-B1 | POLYISOCYANATES CONTAINING SILANE GROUPS BASED ON 1,5-DIISOCYANATOPENTANE | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) | 2024-01-10 | — | — | EP | disclosed |
| US-11795266-B2 | Method for preparing a mixed silane-terminated polymer | COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) | 2023-10-24 | — | — | US | disclosed |
| EP-1022291-A1 | Modified diene elastomer and its preparation | Ube Industries, Ltd. (JP) | 2000-07-26 | — | — | EP | disclosed |
| US-6040101-A | Carrier particles for use in electrostatic image development and electrostatic image developer | NIPPON SHOKUBAI CO., LTD. (JP) | 2000-03-21 | — | — | US | disclosed |
| US-5728770-A | COMPRISING A SILANE, ORGANOMETALLIC COMPOUMD, A COMPOUND WITH TWO FUNCTIONAL GROUPS AND A SOLVENT; EXCELLENT GAS BARRIER PROPERTIES | NIPPON SHOKUBAI CO., LTD. (JP) | 1998-03-17 | — | — | US | disclosed |
| EP-0798054-A2 | Process for producing a coated film continuously | NIPPON SHOKUBAI CO., LTD. (JP) | 1997-10-01 | — | — | EP | disclosed |
| EP-0583581-B1 | Process for making a silylisocyanurate | OSI SPECIALTIES INC (US) | 1997-05-28 | — | — | EP | disclosed |
| EP-0671450-A1 | SURFACE TREATMENT COMPOSITION AND SURFACE-TREATED RESIN MOLDING | NIPPON SHOKUBAI CO., LTD. (JP) | 1995-09-13 | — | — | EP | disclosed |
| EP-0583581-A1 | Process for making a silylisocyanurate | OSi Specialties, Inc. (US) | 1994-02-23 | — | — | EP | disclosed |
| US-5272247-A | Polyimide precursor, cured product thereof, and processes for producing them | HITACHI, LTD. (JP) | 1993-12-21 | — | — | US | disclosed |
| US-5218133-A | Process for making a silylisocyanurate | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 1993-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12594700-B2 | Coatings from polyisocyanurate coatings (rim) and their use in injection molding processes | TST, C9, ESD | DNM1 4874/4885MEN1 1073/4885KMT2A 1410/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.